Guohui Dang
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- MicroRNA in disease regulation
Papers in
-
- Single-cell and spatial transcriptomics 3
- Extracellular vesicles in disease 3
- Advanced biosensing and bioanalysis techniques 1
-
- Atherosclerosis and Cardiovascular Diseases 3
- IL-33, ST2, and ILC Pathways 1
- Co-authors
- NirmalaN Rege (1 shared paper)Juan Feng (5 shared papers)Juan Yang (4 shared papers)Xiaolong Ma (4 shared papers)Yuwei Song (3 shared papers)Huilei Miao (1 shared paper)Xiao Zhao (1 shared paper)Qi Lei (1 shared paper)
- Journals
- The FASEB Journal (1 paper)Phytotherapy Research (1 paper)Cell Reports (1 paper)Signal Transduction and Targeted Therapy (1 paper)Acta Pharmacologica Sinica (1 paper)
- Partner nations
- ChinaUnited KingdomIndia
In The Last Decade
Guohui Dang
10 papers receiving 375 citations
Peers
Comparison fields: 5 of 79
- Biomaterials 65
- Cancer Research 59
- Complementary and alternative medicine 32
- Toxicology 13
- Pharmacology 32
Countries citing papers authored by Guohui Dang
This map shows the geographic impact of Guohui Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guohui Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guohui Dang more than expected).
Fields of papers citing papers by Guohui Dang
This network shows the impact of papers produced by Guohui Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guohui Dang. The network helps show where Guohui Dang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guohui Dang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 122 | |
| 2 | 2010 | 88 | |
| 3 | 2022 | 42 | |
| 4 | 2019 | 35 | |
| 5 | 2023 | 28 | |
| 6 | 2024 | 27 | |
| 7 | 2019 | 20 | |
| 8 | 2021 | 17 | |
| 9 | 2025 | 4 | |
| 10 | 2025 | 1 | |
| 11 | 2025 | 0 |
About Guohui Dang
Guohui Dang is a scholar working on Molecular Biology, Immunology, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 11 papers that have together received 384 indexed citations. Recurring topics across this work include Single-cell and spatial transcriptomics (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Extracellular vesicles in disease (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Nanoplatforms for cancer theranostics (1 paper), Advanced biosensing and bioanalysis techniques (1 paper), IL-33, ST2, and ILC Pathways (1 paper) and Ethnobotanical and Medicinal Plants Studies (1 paper). The work is most often cited by research in Biomaterials (65 citations), Cancer Research (59 citations), Complementary and alternative medicine (32 citations), Toxicology (13 citations) and Pharmacology (32 citations). Guohui Dang has collaborated with scholars based in China, United Kingdom and India. Frequent co-authors include NirmalaN Rege, Juan Feng, Juan Yang, Xiaolong Ma, Yuwei Song, Huilei Miao, Xiao Zhao, Qi Lei, Yuan Fang and Peiwen Ma. Their work appears in journals such as The FASEB Journal, Phytotherapy Research, Cell Reports, Signal Transduction and Targeted Therapy and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.